Identification of a novel family of presenilin homologues

Human Molecular Genetics

Volumn 11, Issue 9, 2002, Pages 1037-1044

  Ponting, Chris P ^a   Hutton, Mike ^b   Nyborg, Andrew ^b   Baker, Matthew ^b   Jansen, Karen ^b   Golde, Todd E ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; ASPARTIC ACID; ASPARTIC PROTEINASE; GAMMA SECRETASE; MEMBRANE PROTEIN; NOTCH RECEPTOR; ONCOPROTEIN; PRESENILIN 1; PRESENILIN 2; PROTEINASE;

ALZHEIMER DISEASE; ANIMAL CELL; ARCHAEBACTERIUM; ARTICLE; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; EUKARYOTE; FUNGUS; GENE MUTATION; GENETIC CONSERVATION; HUMAN; HUMAN CELL; INVERTEBRATE; NONHUMAN; PLANT; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FAMILY; SEQUENCE DATABASE; SEQUENCE HOMOLOGY; VERTEBRATE;

ANIMALIA; ARCHAEA; EUKARYOTA; FUNGI; INVERTEBRATA; VERTEBRATA;

EID: 0036565893     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/11.9.1037     Document Type: Article

References (43)

1. Presenilins as therapeutic targets for the treatment of Alzheimer's disease
2. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
3. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
4. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain
5. Murine notch homologs (n1-4) undergo presenilin-dependent proteolysis
6. γ-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase
7. Notch signaling: From the outside in
8. A transcriptionally active complex of APP with Fe65 and histone acetyltransferase Tip60
9. Subcellular mechanisms of presenilin-mediated enhancement of calcium signaling
10. Presenilin-mediated modulation of capacitative calcium entry
11. Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice
12. Destabilization of β-catenin by mutations in presenilin-1 potentiates neuronal apoptosis
13. Presenilin 1 facilitates the constitutive turnover of beta-catenin: Differential activity of Alzheimer's disease-linked PS1 mutants in the beta-catenin-signaling pathway
14. The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains beta-catenin
15. Effects of PS1 deficiency on membrane protein trafficking in neurons
16. Biochemical detection of Aβ isoforms: Implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease
17. Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency
18. Presenilins are required for γ-secretase cleavage of β-APP and transmembrane cleavage of Notch-1
19. Total inactivation of γ-secretase activity in presenilin-deficient embryonic stem cells
20. Presenilin 1 is linked with γ-secretase activity in the detergent solubilized state
21. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity
22. A loss of function mutation of presenilin-2 interferes with amyloid β-peptide production and notch signaling
23. Peptidomimetic probes and molecular modeling suggest that Alzheimer's gamma-secretase is an intramembrane-cleaving aspartyl protease
24. γ-Secretase, evidence for multiple proteolytic activities and influence of membrane positioning of substrate on generation of amyloid beta peptides of varying length
25. Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin-1
26. Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1
27. Presenilin-1 and -2 are molecular targets for gamma-secretase inhibitors
28. Aspartyl protease inhibitor pepstatin binds to the presenilins of Alzheimer's disease
29. The type 4 prepilin peptidases comprise a novel family of aspartic acid proteases
30. Glycine 384 is required for presenilin-1 function and is conserved in bacterial polytopic aspartyl proteases
31. Improving the accuracy of PSI-BLAST protein database searches with composition-based statistics and other refinements
32. Profile hidden Markov models
33. Hereditary dysphasic disinhibition dementia: A frontotemporal dementia linked to 17q21-22
34. Mapping of a disease locus for familial rapidly progressive frontotemporal dementia to chromosome 17q12-21
35. Chromosome 17 and hereditary dementia: Linkage studies in three non-Alzheimer families and kindreds with late-onset FAD
36. The first proline of PALP motif at the C terminus of presenilins is obligatory for stabilization, complex formation, and gamma-secretase activities of presenilins
37. The PA domain: A protease-associated domain
38. Further evidence for a bipolar risk gene on chromosome 12q24 suggested by investigation of haplotype sharing and allelic association in patients from the Faroe Islands
39. Tau mutations in frontotemporal dementia
40. Molecular genetics of chromosome 17 tauopathies
41. Association of an extended haplotype in the tau gene with progressive supranuclear palsy
42. Corticobasal degeneration shares the same tau haplotype association as progressive supranuclear palsy
43. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice